Applied Genetic Technologies Corporation (AGTC)

[DewDiligence]

AGTC collaborates with (private) Synpromics on novel GT promoters:

http://finance.yahoo.com/news/agtc-synpromics-limited-announce-r-120100753.html

Potential payments to be made by AGTC to Synpromics under the Agreement include a $1.5 million upfront payment, research funding for the collaboration, option exercise fees for each promoter and milestone payments based on clinical and commercial success followed by royalties on sales of products incorporating the covered promoters.

… As part of the collaboration, the companies plan to utilize Synpromics' proprietary technology to develop and optimize synthetic promoters for multiple cell types that will be used in the development of new gene therapy candidates.